학술논문

Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial
Document Type
Article
Source
In The Lancet Infectious Diseases March 2022 22(3):413-425
Subject
Primary Research
Articles
Language
ISSN
1473-3099